CSIMarket Company Name, Ticker, Competitors, else..
 
Notable Labs Ltd   (NASDAQ: NTBL)
 
Price: $0.0000 $0.00 %
Day's High: 0.00 Week Perf:
Day's Low: $ 0.00 30 Day Perf:
Volume (M): 0 52 Wk High: $ 0.00
Volume (M$): $ 0 52 Wk Avg: $0.00
Open: $0.00 52 Wk Low: $0.00



 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) 9
 Employees -
 Revenues (TTM) (Millions $) 0
 Net Income (TTM) (Millions $) -24
 Cash Flow (TTM) (Millions $) -4
 Capital Exp. (TTM) (Millions $) 0

Business Description


Notable Labs, Ltd. is a clinical-stage therapeutics company developing precision medicines for cancer patients through its Predictive Precision Medicines Platform (PPMP). The PPMP bio-simulates cancer treatments ex vivo to predict clinical response, facilitating patient selection and accelerating drug development. The company focuses on in-licensing and developing compounds with demonstrated clinical activity in subsets of patients.


   Company Address: 320 Hatch Drive Foster City 94404 CA
   Company Phone Number: 851-2410   Stock Exchange / Ticker: NASDAQ NTBL


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Management Changes

Notable Labs Announces CEO Transition amid Challenging Financial Performance

Published Mon, Aug 26 2024 8:06 PM UTC



In a recent announcement, Notable Labs Ltd, a pioneering biotech company focused on personalized cancer therapy, disclosed a change in its leadership as Thomas Bock, MD, stepped down as CEO. Joseph Wagner, PhD, the company s Chief Scientific Officer (CSO), has been appointed as the interim CEO. This change comes at a crucial time for Notable Labs as it has reported...
Clinical Study

Unlocking Precision Medicine's Potential: How PPMP-Enriched Volasertib Phase 2 Program Transforms the Treatment of Relapsed/Refractory AML

Published Thu, Feb 22 2024 1:00 PM UTC

Advancing Precision Medicine in Cancer Treatment: The Role of Volasertib in Relapsed/Refractory Acute Myelogenous LeukemiaPrecision medicine has emerged as a promising approach in cancer treatment, aiming to deliver personalized therapies based on individual patient characteristics. Notable Labs, Ltd., a clinical-stage therapeutics company, is at the forefront of this revolu...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) -
Price to Sales (Expected) -
Price to Book -
PEG (TTM) -

Financial Strength Current
Quick Ratio 1.39
Working Capital Ratio 1.45
Leverage Ratio (MRQ) 0.59
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -0.64 $
Revenues (TTM) 0.03 $
Cash Flow (TTM) -
Cash 0.43 $
Book Value 0.76 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) -
Net Income per Employee (TTM) -
Receivable Turnover Ratio (TTM) 2.26
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) 0.01

Profitability Ratios Current
Gross Margin (MRQ) 0 %
Operating Margin (MRQ) -269000 %
Net Margin (MRQ) -260950 %
Net Cash Flow Margin (MRQ) -202200 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -






Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.